For research use only. We do not sell to patients.
EGFR/HER2/CDK9-IN-2
CAS No. : 1180924-34-8
Biological Activity：EGFR/HER2/CDK9-IN-2 (Compound 9) is a potent inhibitor of EGFR/HER2/CDK9 with IC50s of 145.35, 129.07, and 117.13 nM, respectively. EGFR/HER2/CDK9-IN-2 exhibits remarkable antitumor activity.
Research Area：Cancer
Targets：EGFR|CDK
Related Small Molecules:DB0614;NSC81111;Dinaciclib;pp60 (v-SRC) Autophosphorylation Site, Phosphorylated;BMS-690514;SNS-032;CC-671;(E/Z)-Zotiraciclib;Osimertinib-13C,d3;CDK1-IN-4;CCT-251921;BS-181;EGFR-IN-5;FGFR2-IN-3;Samuraciclib hydrochloride hydrate;T025;Flavopiridol;CDK8-IN-3;CDK9-IN-12;FLT3/CDK4-IN-1;Genistein;Epertinib hydrochloride;GFB-12811;GSK 3 Inhibitor IX;Eciruciclib;UNC-CA359;CDK-IN-6
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
